Home » Newsletters » BioWorld Science

BioWorld Science

March 2, 2015

View Archived Issues

Otonomy submits NDA to the FDA for AuriPro

Abivax recruits first patient in pivotal phase IIb/III trial of ABX-203

ReveraGen awarded grant to fun development of VBP-15 for Duchenne muscular dystrophy

Rosetta Genomics updates development progress of microRNA-based thyroid neoplasia assay

Phase II trial initiated of Aduro Biotech's GVAX Pancreas and CRS-207 in combination with nivolumab

Amarin and Eddingpharm sign Vascepa agreement for China

Bovine lactoferrin receives two FDA orphan designations

Triphase Accelerator and Sunnybrook Research Institute to collaborate on TRPH-011

Merck Patent discloses new fatty acid synthase inhibitors

German organization patents GRK5 modulators

Gruenenthal patent reports new CRAC inhibitors

New MEK inhibitors patented by Novartis

Scientists at ICGEB disclose anti-dengue virus vaccine

Lenvima now available in U.S.

Inhibition of HIV RNA biogenesis blocks viral replication and avoids viremia rebound

CHMP recommends conditional marketing approval of ceritinib

EMA's CHMP backs approval of Jinarc for rare kidney disease

EMA committee recommends new approval of Vectibix in metastatic colorectal cancer

FDA postpones meeting to discuss a BLA for Celltrion's CT-P13

Combination therapy shows efficiency for HIV/HCV coinfection treatment

Takeda withdraws new European Rienso submission

ENDEAVOR trial shows superiority of Kyprolis over Velcade in relapsed multiple myeloma

EMA accepts MAA for Santen's intravitreal sirolimus for non-infectious uveitis

Ibalizumab receives FDA breakthrough therapy designation

Rare Disease Day 2015: Focus on new means of developing treatments

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...